ATP1A3-related neurological disorders: updated insights into clinical heterogeneity, molecular mechanisms and precision therapeutics
This narrative review summarizes recent advances in the clinical spectrum, genotype-phenotype correlations, and multilevel pathogenic mechanisms of ATP1A3-related disorders and highlights emerging therapeutic directions, including mechanism-based targeting, antisense strategies, and genome editing approaches such as ba...